Literature DB >> 17710355

First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with Kawasaki disease sequelae using the CROSSER catheter.

N Dahdah1, R Ibrahim, L Cannon.   

Abstract

This is a case of an 11(1/2)-year-old diagnosed with Kawasaki disease at 6 months of age. Distal left main coronary aneurysm involving the proximal anterior descending and circumflex had progressed into a chronic total occlusion. We report the first application of a novel percutaneous technique using the CROSSER catheter system in a child. The CROSSER is a high-frequency mechanical vibration catheter-based technology developed to safely penetrate through calcific and noncalcific coronary artery occlusions. This is also the first Kawasaki disease patient to benefit from this technology; in this disease, coronary artery stenosis is typically associated with heavy calcification.

Entities:  

Mesh:

Year:  2007        PMID: 17710355     DOI: 10.1007/s00246-006-0083-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  15 in total

1.  Catheter interventional treatment in Kawasaki disease: A report from the Japanese Pediatric Interventional Cardiology Investigation group.

Authors:  T Akagi; S Ogawa; T Ino; M Iwasa; S Echigo; K Kishida; K Baba; M Matsushima; K Hamaoka; H Tomita; M Ishii; H Kato
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

2.  Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease.

Authors:  M Ishii; T Ueno; T Akagi; K Baba; K Harada; K Hamaoka; H Kato; E Tsuda; S Uemura; T Saji; S Ogawa; S Echigo; T Yamaguchi; H Kato
Journal:  Pediatr Int       Date:  2001-10       Impact factor: 1.524

3.  Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry.

Authors:  Lutz Buellesfeld; Ulrich Gerckens; Ralf Mueller; Thomas Schmidt; Eberhard Grube
Journal:  Catheter Cardiovasc Interv       Date:  2005-10       Impact factor: 2.692

4.  Images in cardiovascular medicine. Giant coronary aneurysm formation after sirolimus-eluting stent implantation in Kawasaki disease.

Authors:  Steven Siu-Lung Li; Boron Cheung-wah Cheng; Shuk-han Lee
Journal:  Circulation       Date:  2005-08-23       Impact factor: 29.690

5.  A novel approach to chronic total occlusions: the crosser system.

Authors:  Gloria Melzi; John Cosgrave; Giuseppe L Biondi-Zoccai; Flavio Airoldi; Iassen Michev; Alaide Chieffo; Giuseppe M Sangiorgi; Matteo Montorfano; Mauro Carlino; Antonio Colombo
Journal:  Catheter Cardiovasc Interv       Date:  2006-07       Impact factor: 2.692

6.  Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.

Authors:  Angela Migliorini; Guia Moschi; Ruben Vergara; Guido Parodi; Nazario Carrabba; David Antoniucci
Journal:  Catheter Cardiovasc Interv       Date:  2006-03       Impact factor: 2.692

7.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

8.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

9.  Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study.

Authors:  Masahiro Ishii; Takafumi Ueno; Hisao Ikeda; Motofumi Iemura; Tetsu Sugimura; Jun Furui; Yoko Sugahara; Hiromi Muta; Teiji Akagi; Yuichi Nomura; Tomoki Homma; Hiroyoshi Yokoi; Masakiyo Nobuyoshi; Toyojiro Matsuishi; Hirohisa Kato
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

10.  National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan.

Authors:  Etsuko Tsuda; Soichiro Kitamura
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

View more
  6 in total

1.  Novel Percutaneous Coronary Intervention Techniques for Revascularizing Chronically Occluded Giant Coronary Aneurysms in a Patient with Kawasaki Disease.

Authors:  Zachary L Steinberg; Thomas K Jones; William L Lombardi
Journal:  Pediatr Cardiol       Date:  2016-07-09       Impact factor: 1.655

2.  The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976.

Authors:  Ariane McNeal-Davidson; Anne Fournier; Rosie Scuccimarri; Adrian Dancea; Christine Houde; Marc Bellavance; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2012-06-17       Impact factor: 1.655

3.  Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention after Kawasaki Disease: The Pediatric Canadian Series.

Authors:  A Dionne; M Bakloul; C Manlhiot; B W McCrindle; M Hosking; C Houde; D Pepelassis; N Dahdah
Journal:  Pediatr Cardiol       Date:  2016-09-23       Impact factor: 1.655

4.  Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification.

Authors:  Chantale Lapierre; Audrey Bitsch; Ronald Guérin; Laurent Garel; Joaquim Miró; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2009-09-26       Impact factor: 1.655

5.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

Review 6.  The Medical Devices Special Access Program in Canada: A Scoping Study.

Authors:  Roland K Maier; Devidas Menon; Tania Stafinski
Journal:  Healthc Policy       Date:  2018-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.